---
action_items:
- id: 3e6357113d05
  severity: science
  text: Report confidence intervals or standard deviations for all benchmark scores
    (GenEval, DPG-Bench, VBench, MVBench, GEdit-Bench). Single point estimates without
    variance metrics make performance claims unverifiable.
- id: 8d0b83c996d6
  severity: science
  text: "Add statistical significance testing (e.g., paired t-tests, bootstrap CI)\
    \ for ablation study results. Small differences like MaPE (80.56\u219280.94 GenEval)\
    \ require significance validation."
- id: bb8f402b7958
  severity: science
  text: Apply multiple-comparisons correction (Bonferroni, FDR) when reporting best/second-best
    across 20+ VBench metrics and 20+ MVBench sub-metrics. Current claims risk false
    positives.
- id: 83e67c05feb0
  severity: science
  text: Document number of evaluation runs per benchmark (seeds, repetition count).
    Reproducibility requires variance reporting across independent runs.
artifact_hash: 98907cd56a010d460341428f6fc0e64bb073af6070fb95425426ecc033d84afb
artifact_path: projects/PROJ-603-https-arxiv-org-abs-2605-18678/paper/metadata.json
backend: dartmouth
feedback: ''
github_authenticated: false
model_name: qwen.qwen3.5-122b
prompt_version: 1.1.0
reviewed_at: '2026-06-01T20:00:00.860611Z'
reviewer_kind: llm
reviewer_name: paper_reviewer_statistical_analysis
score: 0.0
verdict: full_revision
---

The paper presents extensive benchmark comparisons but lacks rigorous statistical analysis to support performance claims. Key concerns:

**Benchmark Reporting (Tables: image_generation_combined, vbench_full, mvbench_main, gedit_bench)**: All scores are single point estimates (e.g., VBench Total Score 85.11, GenEval 0.90). No confidence intervals, standard deviations, or multiple-run averages are provided. This makes it impossible to assess whether claimed improvements (e.g., 85.11 vs Show-o2's 81.34) are statistically significant or within evaluation noise.

**Ablation Studies (Tables: ablation_auxiliary_data_generation, ablation_mape)**: Small performance differences are reported without significance testing. For example, MaPE improves GenEval from 80.56 to 80.94 (0.38 points). Without p-values or bootstrap analysis, these could reflect random variation. The cross-task data ablation shows similar issues—differences of 0.1–0.5 points across metrics lack statistical validation.

**Multiple Comparisons**: The paper identifies "best" and "second-best" across 20+ VBench metrics, 20+ MVBench sub-metrics, and 7 GenEval sub-metrics. No correction for multiple hypothesis testing is applied, inflating false positive risk.

**Scaling Analysis (Figure: token_scaling_curve)**: Performance-vs-tokens curves show no error bars or confidence bands. Scaling claims lack uncertainty quantification.

**Recommendations**: (1) Run each benchmark ≥3 times with different seeds and report mean±std. (2) Add statistical tests comparing Lance to top baselines. (3) Apply FDR or Bonferroni correction when claiming superiority across multiple metrics. (4) Include evaluation variance in all ablation comparisons. These changes are essential for validating empirical claims.
